Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Thrombotic thrombocytopenic purpura with an autoantibody to ADAMTS13 complicating Sjögren's syndrome: two cases and a literature review.

Yamashita H, Takahashi Y, Kaneko H, Kano T, Mimori A.

Mod Rheumatol. 2013 Mar;23(2):365-73. doi: 10.1007/s10165-012-0644-7. Epub 2012 Apr 21. Review.

PMID:
22526830
2.

Thrombotic thrombocytopenic purpura as an initial presentation of primary Sjögren's syndrome.

Schattner A, Friedman J, Klepfish A.

Clin Rheumatol. 2002 Feb;21(1):57-9. Review.

PMID:
11954887
3.

[Thrombotic thrombocytopenic purpura: a case report].

Garcia-Hejl C, Fagot T, Foissaud V, Samson T, Defuentes G, Clavier B, Perez JP, de Revel T.

Ann Biol Clin (Paris). 2008 May-Jun;66(3):327-31. doi: 10.1684/abc.2008.0206. French.

4.

ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.

Tersteeg C, Verhenne S, Roose E, Schelpe AS, Deckmyn H, De Meyer SF, Vanhoorelbeke K.

Expert Rev Hematol. 2016;9(2):209-21. doi: 10.1586/17474086.2016.1122515. Epub 2015 Dec 8. Review.

PMID:
26581428
5.

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.

Thomas MR, de Groot R, Scully MA, Crawley JT.

EBioMedicine. 2015 Jun 11;2(8):942-52. doi: 10.1016/j.ebiom.2015.06.007. eCollection 2015 Aug.

6.

Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.

Jian C, Xiao J, Gong L, Skipwith CG, Jin SY, Kwaan HC, Zheng XL.

Blood. 2012 Apr 19;119(16):3836-43. doi: 10.1182/blood-2011-12-399501. Epub 2012 Jan 30.

7.

[anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura].

Matsumoto M.

Nihon Rinsho Meneki Gakkai Kaishi. 2013;36(2):95-103. Review. Japanese.

8.

Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.

Yamaguchi Y, Moriki T, Igari A, Nakagawa T, Wada H, Matsumoto M, Fujimura Y, Murata M.

Thromb Res. 2011 Aug;128(2):169-73. doi: 10.1016/j.thromres.2011.03.010. Epub 2011 Apr 14.

PMID:
21496883
9.

The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.

Starke R, Machin S, Scully M, Purdy G, Mackie I.

Br J Haematol. 2007 Feb;136(4):649-55.

PMID:
17367414
10.

Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura.

Luken BM, Kaijen PH, Turenhout EA, Kremer Hovinga JA, van Mourik JA, Fijnheer R, Voorberg J.

J Thromb Haemost. 2006 Nov;4(11):2355-64. Epub 2006 Aug 8.

11.

Interferon-α is not elevated in idiopathic thrombotic thrombocytopenic purpura patients.

Watanaboonyongcharoen P, Whinna HC, Park YA.

J Clin Apher. 2014 Dec;29(6):336-8. doi: 10.1002/jca.21322. Epub 2014 Apr 25.

PMID:
24764259
12.

A 9-month-old infant with acquired idiopathic thrombotic thrombocytopenic purpura caused by inhibitory IgG-autoantibody to ADAMTS13.

Sato A, Hoshi Y, Onuma M, Sato R, Tsunematsu Y, Isonishi A, Matsumoto M, Fujimura Y, Imaizumi M.

Pediatr Hematol Oncol. 2010 Feb;27(1):53-8. doi: 10.3109/08880010903401752.

PMID:
20121555
13.

Defective ADAMTS13 synthesis as a possible consequence of NASH in an obese patient with recurrent thrombotic thrombocytopenic purpura.

Lombardi AM, Fabris R, Berti de Marinis G, Marson P, Navaglia F, Plebani M, Vettor R, Fabris F.

Eur J Haematol. 2014 Jun;92(6):497-501. doi: 10.1111/ejh.12273. Epub 2014 Feb 20.

PMID:
24460705
14.

Current insight into thrombotic thrombocytopenic purpura.

Verbeke L, Delforge M, Dierickx D.

Blood Coagul Fibrinolysis. 2010 Jan;21(1):3-10. doi: 10.1097/MBC.0b013e32833335eb. Review.

PMID:
19851089
15.

Acquired TTP: ADAMTS13 meets the immune system.

Verbij FC, Fijnheer R, Voorberg J, Sorvillo N.

Blood Rev. 2014 Nov;28(6):227-34. doi: 10.1016/j.blre.2014.07.004. Epub 2014 Aug 15. Review.

PMID:
25213289
17.

Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura.

Zheng XL, Wu HM, Shang D, Falls E, Skipwith CG, Cataland SR, Bennett CL, Kwaan HC.

Haematologica. 2010 Sep;95(9):1555-62. doi: 10.3324/haematol.2009.019299. Epub 2010 Apr 7.

18.

ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.

Tsai HM, Raoufi M, Zhou W, Guinto E, Grafos N, Ranzurmal S, Greenfield RS, Rand JH.

Thromb Haemost. 2006 May;95(5):886-92.

19.

High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome.

Casina VC, Hu W, Mao JH, Lu RN, Hanby HA, Pickens B, Kan ZY, Lim WK, Mayne L, Ostertag EM, Kacir S, Siegel DL, Englander SW, Zheng XL.

Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9620-5. doi: 10.1073/pnas.1512561112. Epub 2015 Jul 22.

20.

Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene.

Rank CU, Kremer Hovinga J, Taleghani MM, Lämmle B, Gøtze JP, Nielsen OJ.

Eur J Haematol. 2014 Feb;92(2):168-71. doi: 10.1111/ejh.12197. Epub 2013 Dec 10.

PMID:
24033710

Supplemental Content

Support Center